Inhibitors of growth factor receptors, signaling pathways and angiogenesis as therapeutic molecular agents

Cancer Metastasis Rev. 2006 Jun;25(2):243-52. doi: 10.1007/s10555-006-8504-6.
No abstract available

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / metabolism
  • Angiogenesis Inhibitors / therapeutic use*
  • Animals
  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Humans
  • Neoplasms / drug therapy*
  • Pericytes / drug effects
  • Receptor, ErbB-2 / immunology
  • Receptors, Growth Factor / antagonists & inhibitors*
  • Signal Transduction / drug effects*
  • Vascular Endothelial Growth Factor C / metabolism
  • Vascular Endothelial Growth Factor Receptor-3 / metabolism

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Receptors, Growth Factor
  • Vascular Endothelial Growth Factor C
  • Receptor, ErbB-2
  • Vascular Endothelial Growth Factor Receptor-3